WuXi Biologics

WuXi Biologics is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) specializing in biologics. They offer end-to-end solutions that enable partners to discover, develop, and manufacture biologics, from the initial concept to commercialization. WuXi Biologics has a global presence, operating in China, the United States, Ireland, Germany, and Singapore, with over 12,000 skilled employees. They leverage their technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development, and manufacturing solutions.

WuXi Biologics is known for its strong commitment to Environmental, Social, and Governance (ESG) practices. They have been recognized by major ESG rating agencies such as Sustainalytics, MSCI, and EcoVadis for their sustainability performance. Their facilities utilize next-generation biomanufacturing technologies and clean-energy sources, and they are committed to reducing their environmental impact. They also have a dedicated ESG committee led by their CEO to steer the comprehensive ESG strategy and its implementation.

WuXi Biologics' mission is to build an open-access platform with comprehensive capabilities and technologies in the global biologics industry, enabling the creation of every drug and the treatment of every disease. They aim to accelerate and transform the biologics discovery, development, and manufacturing process, empowering partners and benefiting patients worldwide.

WuXi Biologics promotes a culture focused on accelerating and transforming biologics discovery, development, and manufacturing for the benefit of patients worldwide. They emphasize a commitment to providing a truly ONE-stop service offering and value proposition to their global clients, fostering a collaborative and innovative environment. This commitment is evident in their extensive partnerships with pharmaceutical and biotech companies, dedication to practicing global-standard corporate governance, and dedication to Environmental, Social, and Governance (ESG) practices.

WuXi Biologics prioritizes diversity, equity, and inclusion (DE&I) as a core component of its business strategy and commitment to fostering a workplace where every employee can reach their full potential. The company actively promotes DE&I through various initiatives, including establishing a DE&I Committee, hosting WiSTEM campaigns and science camps, and being recognized for its efforts by organizations like sHero, earning the Prime Employers for Women Award for two consecutive years.